257 related articles for article (PubMed ID: 1377057)
21. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
22. Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations.
Williams N; Bertoncello I; Kavnoudias H; Zsebo K; McNiece I
Blood; 1992 Jan; 79(1):58-64. PubMed ID: 1370209
[TBL] [Abstract][Full Text] [Related]
23. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
24. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H
Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685
[TBL] [Abstract][Full Text] [Related]
25. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor.
Molineux G; Migdalska A; Szmitkowski M; Zsebo K; Dexter TM
Blood; 1991 Aug; 78(4):961-6. PubMed ID: 1714329
[TBL] [Abstract][Full Text] [Related]
26. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.
Tsuji K; Zsebo KM; Ogawa M
Blood; 1991 Sep; 78(5):1223-9. PubMed ID: 1715219
[TBL] [Abstract][Full Text] [Related]
28. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
29. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.
de Revel T; Appelbaum FR; Storb R; Schuening F; Nash R; Deeg J; McNiece I; Andrews R; Graham T
Blood; 1994 Jun; 83(12):3795-9. PubMed ID: 7515722
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta inhibits the action of stem cell factor on mouse and human hematopoietic progenitors.
McNiece IK; Bertoncello I; Keller JR; Ruscetti FW; Hartley CA; Zsebo KM
Int J Cell Cloning; 1992 Mar; 10(2):80-6. PubMed ID: 1372030
[TBL] [Abstract][Full Text] [Related]
32. In vivo hematological effects of seven days of rhIL-6 in neonatal rats.
Cairo MS; Plunkett JM; Clark S; van de Ven C
Am J Pediatr Hematol Oncol; 1992; 14(1):44-7. PubMed ID: 1550262
[TBL] [Abstract][Full Text] [Related]
33. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
35. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
36. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
37. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors.
Berger C; Bertz H; Schmoor C; Behringer D; Potthoff K; Mertelsmann R; Finke J
Bone Marrow Transplant; 1999 May; 23(10):983-90. PubMed ID: 10373062
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
McNiece IK; Langley KE; Zsebo KM
Exp Hematol; 1991 Mar; 19(3):226-31. PubMed ID: 1704845
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Schuening FG; Appelbaum FR; Deeg HJ; Sullivan-Pepe M; Graham TC; Hackman R; Zsebo KM; Storb R
Blood; 1993 Jan; 81(1):20-6. PubMed ID: 7678065
[TBL] [Abstract][Full Text] [Related]
40. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
